90564-41-3

Basic information

• Product Name: 2,4-diMethoxy-5-nitrobenzoic acid
• Synonyms: 2,4-diMethoxy-5-nitrobenzoic acid
• CAS NO: 90564-41-3
• Molecular Formula: C₉H₉NO₆
• Molecular Weight: 227.17086
• EINECS: -0
• Mol File: 90564-41-3.mol
• Article Data: 7

Chemical Properties

• Melting Point: 220 °C
• Boiling Point: 419.1±45.0 °C(Predicted)
• Appearance: /
• Density: 1.403±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 3.71±0.12(Predicted)
• CAS DataBase Reference: 2,4-diMethoxy-5-nitrobenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-diMethoxy-5-nitrobenzoic acid(90564-41-3)
• EPA Substance Registry System: 2,4-diMethoxy-5-nitrobenzoic acid(90564-41-3)

Safety Data

• Hazardous Substances Data: 90564-41-3(Hazardous Substances Data)

Usage

General Description

2,4-diMethoxy-5-nitrobenzoic acid is a chemical compound with the molecular formula C10H9NO6. It is a yellow crystalline powder with a molecular weight of 239.18 g/mol. 2,4-diMethoxy-5-nitrobenzoic acid is commonly used in organic synthesis and pharmaceutical research. It is known for its nitro and methoxy functional groups, which make it useful for various applications including as a precursor in the synthesis of pharmaceutical drugs and other biologically active compounds. Additionally, 2,4-diMethoxy-5-nitrobenzoic acid may also be utilized in the development of new materials and dyes. It is important to handle this chemical with care, as it can pose health and environmental hazards.

Upstream product

• 91-52-1 2,4 dimethoxybenzoic acid 
• 81574-75-6 2,4-dimethoxy-5-nitro-benzoic acid methyl ester 
• 19861-62-2 2,4-dichloro-5-nitrobenzoic acid 
• 124-41-4 sodium methylate 
• 68255-77-6 2-methoxy-4-chloro-5-nitrobenzoic acid 
• 2597-56-0 4-nitro-o-anisic acid 
• 403-24-7 2-fluoro-4-nitrobenzoic acid 
• 13120-77-9 2-methyl-5-nitroanisole 
• 271261-71-3 2,4-dihydroxy-5-nitro-benzoic acid methyl ester 
• 13722-96-8 2,4-dihydroxy-5-nitrobenzoic acid 
• 89-86-1 4-hydroxysalicylic acid 
• 16909-09-4 (E)-3-(2,4-dimethoxyphenyl)-2-propenoic acid 
• 115919-39-6 2-methoxy-4,5-dinitrobenzoic acid 
• 393-95-3 2-fluoro-4,5-dinitro-benzoic acid 

Downstream Products

• 778599-56-7 1-bromo-2,4-dimethoxy-5-nitrobenzene 
• 174261-19-9 5-amino-2,4-dimethoxy-benzoic acid 
• 271261-78-0 3-(5-(2,4-dimethoxy-5-nitrobenzoylamino)-2,4-dioctyloxybenzoylamino)-4-methoxytoluene 
• 81574-75-6 2,4-dimethoxy-5-nitro-benzoic acid methyl ester 
• 214470-27-6 7-methoxy-4-hydroxy-6-nitroquinoline-3-carbonitrile 
• 214470-33-4 4-chloro-7-methoxy-6-nitro-quinoline-3-carbonitrile 
• 214485-59-3 4-(3-Chloro-4-fluoro-phenylamino)-7-methoxy-6-nitro-quinoline-3-carbonitrile 
• 214485-60-6 6-amino-4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinoline-3-carbonitrile 
• 1383808-70-5 C₆₁H₈₆N₄O₂₇ 
• 1383808-65-8 C₄₉H₈₂N₂O₇ 
• 1383808-81-8 C₃₀H₄₂N₂O₁₅ 
• 1383808-80-7 C₄₈H₇₈N₂O₉ 
• 1383808-79-4 C₃₁H₄₄N₂O₁₅ 

Relevant articles and documents

4-quinazoline amine derivatives and their use

A 4-quinazoline amine derivative as represented by formula (1), a pharmaceutical composition comprising the derivative, and an application thereof in preparing medicine for curing cancer. The cancer is a drug-resistant cancer, preferably a cancer resisting an EGFR reversible inhibitor, and more preferably, a cancer resisting gefitinib, erlotinib or lapatinib; alternatively, the cancer carries EGFR mutation.

A new class of folding oligomers: Crescent oligoamides [4]

-

Antibiotic compounds

The present invention relates to carbapenems and provides a compound of the formula (I): STR1 or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof wherein: R1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl; R2 is hydrogen or C1-4 alkyl; R3 is hydrogen or C1-4 alkyl; R4 and R5 are the same or different and are selected from hydrogen, halo, cyano, C1-4 alkyl, nitro, hydroxy, carboxy, C1-4 alkoxy, C1-4 alkoxycarbonyl, aminosulphonyl, C1-4 alkylaminosulphonyl, di-C1-4 alkylaminosulphonyl, carbamoyl, C1-4 alkylcarbamoyl, di-C1-4 alkylcarbamoyl, trifluoromethyl, sulphonic acid, amino, C1-4 alkylamino, di-C1-4 alkylamino, C1-4 alkanoylamino, C1-4 alkanoyl(N-C1-4 alkyl)amino, C1-4 alkanesulphonamido and C1-4 alkylS(O)n -- wherein n is zero, one or two: with the proviso that there is no hydroxy or carboxy substituent in a position ortho to the --NR2 --. Processes for their preparation, intermediates in their preparation, their use as therapeutic agents and pharmaceutical compositions containing them.